In line with previously published results, we found that the expression level of miR-370-3p was not associated with prolonged value for survival in the analyzed GBM patients (from which GSCs are derived) (p = 0.0911; Hazard Ratio (HR) 0.4778; 95% CI from 0.2029 to 1.1253) [44], while high NEAT1 expression was associated to unfavorable overall survival (OS) (p = 0.035; HR 2.7980; 95% CI from 1.0754 to 7.2804) [43] (Figure 5A,B). This evidence concerns the gene NEAT1 and glioblastoma.